Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors

Autores/as

  • Darren Taichman
  • Joyce Backus
  • Christopher Baethge Chief Scientific Editor Deutsches Ärzteblatt (German Medical Journal) and Deutsches Ärzteblatt International
  • Howard Bauchner
  • Peter de Leeuw Dept of Medicine, Maastricht University Medical Center
  • Jeffrey Drazen Editor-in-Chief New England Journal of Medicine
  • John Fletcher CMAJ Canadian Medical Association Journal
  • Francis Frizelle Editor in Chief, The New Zealand Medical Journal.
  • Trish Groves Head of Research, BMJ & Editor-in-chief, BMJ Open
  • Abraham Haileamlak Ethiopian Journal of Health Sciences
  • Astrid James
  • Christine Laine Annals of Internal Medicine
  • Larry Peiperl PLOS Medicine
  • Anja Pinborg Ugeskrift for Laeger/Danish Medical Journal
  • Peush Sahni The National Medical Journal of India
  • Sinan Wu Chinese Medical Journal

Resumen

The International Committee of Medical Journal Editors (ICMJE) believes that there is an ethical obligation to responsibly share data generated by interventional clinical trials because participants have put themselves at risk.In a growing consensus, many funders around the world—foundations, government agencies, and industry—now mandate data sharing. Here we outline ICMJE’s proposed requirements to help meet this obligation.We encourage feedback on the proposed requirements. Anyone can provide feedback at www.icmje.org by 18 April 2016. The ICMJE defines a clinical trial as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome.Further details may be found in the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals at www.icmje.org. As a condition of consideration for publication of a clinical trial report in our member journals, the ICMJE proposes to require authors to share with others the deidentified individual-patient data (IPD) underlying the results presented in the article(including tables, figures, and appendices or supplementary material) no later than 6 months after publication. The data underlying the results are defined as the IPD required toreproduce the article’s findings, including necessary metadata.This requirement will go into effect for clinical trials that begin to enroll participants beginning 1year after the ICMJE adoptsits data-sharingrequirements.* Enabling responsible data sharing is a major endeavor that will affect the fabric of how clinical trials are planned and conducted and how their data are used.By changing the requirements of the manuscripts we will consider for publication in our journals, editors can help foster this endeavor. As editors, our direct influence is logically, and practically, limited to those data underpinning the results and analyses we publish in our journals.

Descargas

Publicado

2015-12-17

Cómo citar

Taichman, D., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P., Drazen, J., Fletcher, J., Frizelle, F., Groves, T., Haileamlak, A., James, A., Laine, C., Peiperl, L., Pinborg, A., Sahni, P., & Wu, S. (2015). Sharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors. Revista Médica De Chile, 144(1). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/4742

Número

Sección

Editorial

Artículos más leídos del mismo autor/a